Drug Profile
Parathyroid hormone (1-84) - Kerun Biopharmaceutical
Alternative Names: Recombinant human parathyroid hormone (PTH) 1-84 - Kerun; rhPTH (1-84) - KerunLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Kerun Biopharmaceutical
- Developer Heze Buchang Pharmaceutical; Kerun Biopharmaceutical
- Class Calcium regulators; Osteoporosis therapies; Peptide hormones; Recombinant proteins
- Mechanism of Action Osteogenesis stimulants; Parathyroid hormone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Osteoporosis
Most Recent Events
- 28 Apr 2019 No recent reports of development identified for phase-I development in Osteoporosis in China (SC, Injection)